IGF-1 LR3 1MG

Description

IGF-1 LR3 is a recombinant analog of Insulin-like Growth Factor-1 modified with an arginine substitution and an N-terminal extension to extend its research-relevant half-life. It has been characterized in the research literature for studies in cellular-growth, somatic-signaling, and regenerative-research models. Nova supplies IGF-1 LR3 in a 1mg lyophilized vial that requires reconstitution with a suitable solvent before research use. Every batch is triple-tested by an independent, ISO/IEC 17025-accredited laboratory. Every vial ships with a QR code linked to its batch Certificate of Analysis. For research use only. Not for human or animal consumption.